Effects of treatment with glucagon-like peptide-2 on bone resorption in colectomized patients with distal ileostomy or jejunostomy and short-bowel syndrome

By Gottschalck Ida   Jeppesen Palle   Hartmann Bolette   Holst Jens   Henriksen Dennis  

Scandinavian Journal of Gastroenterology, Vol. 43, Iss. 11, 2008-01 ,pp. : 1304-1310

Informa Healthcare

Access to resources Recommend Favorite

Reduction in bone resorption by exogenous glucagon-like peptide-2 administration requires an intact gastrointestinal tract

By Gottschalck Ida   Jeppesen Palle   Holst Jens   Henriksen Dennis  

Scandinavian Journal of Gastroenterology, Vol. 43, Iss. 8, 2008-01 ,pp. : 929-937

Informa Healthcare

Access to resources Recommend Favorite

Glucagon-like Peptide 2

By Drucker D.J.  

Trends in Endocrinology and Metabolism, Vol. 10, Iss. 4, 1999-05 ,pp. : 153-156

Elsevier

Access to resources Recommend Favorite

Role of vesicle-associated membrane protein 2 in exocytosis of glucagon-like peptide-1 from the murine intestinal L cell

By Li Samantha   Zhu Dan   Gaisano Herbert   Brubaker Patricia  

Diabetologia, Vol. 57, Iss. 4, 2014-04 ,pp. : 809-818

Springer Publishing Company

Access to resources Recommend Favorite

Glucagon-like peptide-2 inhibits antral emptying in man, but is not as potent as glucagon-like peptide-1

By Nagell C. F.   Wettergren A.   Pedersen J. F.   Mortensen D.   Holst J. J.  

Scandinavian Journal of Gastroenterology, Vol. 39, Iss. 4, 2004-04 ,pp. : 353-358

Informa Healthcare

Access to resources Recommend Favorite